Critical Reviews in Oncology / Hematology
Volume 74, Issue 1 , Pages 66-71 , April 2010

Curative external beam radiotherapy in patients over 80 years of age with localized prostate cancer: A retrospective rare cancer network study

  • Tan Dat Nguyen

      Affiliations

    • Institute Jean-Godinot, Reims, France
    • Corresponding Author InformationCorresponding author at: Department of Radiation Oncology, Institute Jean-Godinot Regional Cancer Centre, 1 rue du Général-Koenig, 51100 Reims, France. Tel.: +33 326504350; fax: +33 326504369.
    • ,
  • David Azria

      Affiliations

    • Centre Val d’Aurelle, Montpellier, France
    • ,
  • Daniele Brochon

      Affiliations

    • CHRU de Grenoble, France
    • ,
  • Philip Poortmans

      Affiliations

    • Dr B. Verbeteen Institute, Tilburg, The Netherlands
    • ,
  • Robert C. Miller

      Affiliations

    • Mayo Clinic and Mayo Foundation, Rochester, MN, USA
    • ,
  • Luciano Scandolaro

      Affiliations

    • Ospedale Santa Anna, Como, Italy
    • ,
  • Wojciech Majewski

      Affiliations

    • Memorial Cancer Center and Institute of Oncology, Warsaw, Poland
    • ,
  • Marco Krengli

      Affiliations

    • Hospital Maggiore della Carità, Novara, Italy
    • ,
  • Ufuk Abacioglu

      Affiliations

    • Marmara University Hospital, Istanbul, Turkey
    • ,
  • Luigi Moretti

      Affiliations

    • Institut Jules Bordet, Bruxelles, Belgium
    • ,
  • Salvador Villa

      Affiliations

    • Institut Catala de Oncologia, Hospitalet, Spain
    • ,
  • Fadil Akyol

      Affiliations

    • Hacettepe University, Ankara, Turkey
    • ,
  • Nicolas Jovenin

      Affiliations

    • Institute Jean-Godinot, Reims, France

,Accepted 2 April 2009.

References 

  1. Vercelli M, Quaglia A, Marani E, et al. Prostate cancer incidence and mortality trends among elderly and adult Europeans. Crit Rev Oncol Hematol. 2000;35(135):144
  2. Geinitz H, Zimmermann FB, Thamm R, et al. 3D conformal radiation therapy for prostate cancer in elderly patients. Radiother Oncol. 2005;76:27–34
  3. Jani AB, Panikh SD, Vijayakumar S, et al. Analysis of influence of age on acute and chronic radiotherapy toxicity in treatment of prostate cancer. Urology. 2005;65:1157–1162
  4. Pignon T, Horiot JC, Bolla M, et al. Age is not a limiting factor for radical radiotherapy in pelvic malignancies. Radiother Oncol. 1997;42:107–112
  5. Stromberg J, Kestin L, Gustafson G, et al. Acute and late toxicity in men ≥70 years old compared with men <70 years old treated with high dose rate prostate brachytherapy boost and pelvic external irradiation for prostate cancer. Int J Radiat Oncol Biol Phys Abstr. 2001;51:308
  6. Villa S, Bedini N, Fallai C, et al. External beam radiotherapy in elderly patients with clinically localized prostate adenocarcinoma: age is not a problem. Crit Rev Oncol Hematol. 2003;48:215–225
  7. Greenfield S, Apolone G, McNeil BJ, et al. The importance of co-existent disease in the occurrence of postoperative complication and one-year recovery in patients undergoing total hip replacement. Co-morbidity and outcomes after hip replacement. Med Care. 1993;31:141–154
  8. Fouad MN, Mayo CP, Funkhouser EM, et al. Co-morbidity independently predicted death in older prostate cancer patients, more of them died with rather than from their diseases. J Clin Epidemiol. 2004;57:721–729
  9. Scherr D, Swindle PW, Scardino PT. National Comprehensive Cancer Network Guidelines for the management of prostate cancer. Urology. 2003;61:14–24
  10. Blood PA, Pickles T. the median non-prostate cancer survival is more than 10 years for men up to age 80 years who are selected and receive curative radiation treatment for prostate cancer. Radiat Oncol. 2007;2:17–20
  11. Buboltz T, Wasson JH, Lu-Yao G, et al. Treatments for prostate cancer in older men: 1984–1997. Urology. 2001;58:977–982
  12. Houterman S, Janssen-Heijnen MLG, Hendrikx AJM, et al. Impact of comorbidity on treatment and prognosis of prostate cancer: a population-based study. Crit Rev Oncol Hematol. 2006;58:60–67
  13. Alibhai SM, Krahn MD, Cohen MM, et al. Is there an age bias in the treatment of localized prostate carcinoma. Cancer. 2004;100:72–82
  14. Schwartz KL, Alibhai ML, Tomlinson G, et al. Continued under-treatment of older men with localized prostate cancer. Urology. 2003;62:860–865
  15. Fowler JE, Terrell FL, Renfroe LD. Co-morbidities and survival of men with localized prostate cancer treated with surgery or radiation therapy. J Urol. 1996;156:1714–1718
  16. Albertsen PC, Fryback DG, Storer BE, et al. The impact of co-morbidity on life expectancy among men with localized prostate cancer. J Urol. 1996;156:127–132
  17. Satariano WA, Ragland KE, Van den Eeden SK. Cause of death in men diagnosed with prostate carcinoma. Cancer. 1998;83:1180–1188
  18. Aus G, Hugosson J, Norlen L. Long term survival and mortality in prostate cancer treated with noncurative intent. J Urol. 1995;154:613–621
  19. Newshaffer CJ, Otani K, McDonald MK, et al. Causes of death in elderly prostate cancer patients and in a comparison non-prostate cancer patients. J Natl Cancer Inst. 2000;92(8):613–621
  20. Ogawa K, Onishi H, Koizumi M, et al. Influence of age on the pattern and outcome of external beam radiotherapy for clinically localized prostate cancer. Anticancer Res. 2006;26:1319–1325
  21. Fransson P, Widmark A. 15-year prospective follow-up of patient-reported outcomes of late bowel toxicity after external beam radiotherapy for localized prostate cancer. A comparison with age-matched controls. Acta Oncol. 2007;46:517–524
  22. Balducci L, Extermann M. Management of the frail person with advanced cancer. Crit Rev Oncol Hematol. 2000;33:143–148
  23. Monfardini S, Ferucci L, Fratino L. Validation of a multidimensional evaluation scale for use in the elderly cancer patients. Cancer. 1996;77:394–401
  24. Rockwood K, Stadnyck K, MacKnight C, et al. A brief clinical instrument to classify frailtry in elderly people. Lancet. 1999;353:205–206
  25. Fentiman IS, Tirelli U, Monfardini S, et al. Cancer in the elderly: why so badly treated. Lancet. 1990;335:1020–1022
  26. Wymenga ANM, Slaets JPJ, Sleijfer DTh. Treatment of cancer in old age, shortcomings and challenges. Neth J Med. 2001;59:259–266

PII: S1040-8428(09)00081-X

doi: 10.1016/j.critrevonc.2009.04.004

Critical Reviews in Oncology / Hematology
Volume 74, Issue 1 , Pages 66-71 , April 2010

Article Tools

* Image Usage & Resolution